In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Fate Therapeutics Inc (NASDAQ: FATE) closed at $0.91 in the last session, down -2.43% from day before closing price of $0.94. In other words, the price has decreased by -$2.43 from its previous closing price. On the day, 1.16 million shares were traded. FATE stock price reached its highest trading level at $0.9389 during the session, while it also had its lowest trading level at $0.9038.
Ratios:
We take a closer look at FATE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.58 and its Current Ratio is at 7.58. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.24.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Wolchko J Scott bought 113,178 shares for $0.93 per share.
Bressi Jerome Charles sold 5,980 shares of FATE for $9,269 on Jan 10 ’25. The insider now owns 270,203 shares after completing the transaction at $1.55 per share. On Jan 10 ’25, another insider, TAHL CINDY, who serves as the insider of the company, sold 5,654 shares for $1.55 each. As a result, the insider received 8,764 and left with 336,707 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 104730200 and an Enterprise Value of -89069416. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.68 while its Price-to-Book (P/B) ratio in mrq is 0.33. Its current Enterprise Value per Revenue stands at -6.534 whereas that against EBITDA is 0.504.
Stock Price History:
The Beta on a monthly basis for FATE is 2.36, which has changed by -0.86754 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, FATE has reached a high of $7.70, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -25.21%, while the 200-Day Moving Average is calculated to be -66.41%.
Shares Statistics:
According to the various share statistics, FATE traded on average about 2.39M shares per day over the past 3-months and 1527430 shares per day over the past 10 days. A total of 113.93M shares are outstanding, with a floating share count of 103.48M. Insiders hold about 14.06% of the company’s shares, while institutions hold 85.14% stake in the company. Shares short for FATE as of 1740700800 were 13328335 with a Short Ratio of 5.59, compared to 1738281600 on 12869655. Therefore, it implies a Short% of Shares Outstanding of 13328335 and a Short% of Float of 13.33.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
